Skip to main content
. 2012 Oct 10;13(10):12925–12938. doi: 10.3390/ijms131012925

Table 2.

The association between clinicopathologic data of the effusion cohort and HAS/HYAL expression (p-value).

Clinical Parameter Enzyme

HAS1 HAS2 HAS3 HYAL2v1 HYAL2v2 HYAL3wt HYAL3v1-3
Effusion site 0.4 0.28 0.76 0.23 0.97 0.9 0.37
Age 0.71 0.23 0.68 0.84 0.18 0.4 0.89
FIGO stage 0.06 0.15 0.62 0.61 0.77 0.8 0.54
RD volume 0.78 0.54 0.31 0.15 0.87 0.19 0.54
Chemoresponse 0.99 0.59 0.3 0.94 0.23 0.35 0.06
Previous chemotherapy <0.001 0.23 0.5 0.016 0.79 0.024 0.34
Previous platinum <0.001 0.4 0.83 0.17 0.71 0.06 0.82
Previous paclitaxel 0.003 0.24 0.72 0.43 0.58 0.005 0.54